Graves' disease after treatment with Alemtuzumab for multiple sclerosis. Tsourdi E, Gruber M, Rauner M, Blankenburg J, Ziemssen T, Hofbauer LC Hormones (Athens). 2014 Nov 5. PMID: 25402383. Abstract CommentRecommendBookmarkWatch